Antibe Therapeutics Inc. clinical trials
Acquired by Sun Pharmaceutical Industries Limited
The registry lists 3 studies whose lead sponsor is Antibe Therapeutics Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 21, 2022.
Registry sponsor names on this page
- Antibe Therapeutics Inc.3 studies
Something wrong with this grouping? Tell us on the Sun Pharmaceutical Industries Limited page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Sun Pharmaceutical Industries Limited studies →
- Efficacy and Safety of ATB-346 Versus Placebo in Osteoarthritis PatientsCompletedNCT03978208Phase 2
Sponsor listed in the registry: Antibe Therapeutics Inc. · Antibe Therapeutics Inc. — acquired company within the Sun Pharmaceutical Industries Limited group
- To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy SubjectsCompletedNCT03291418Phase 1/2
Sponsor listed in the registry: Antibe Therapeutics Inc. · Antibe Therapeutics Inc. — acquired company within the Sun Pharmaceutical Industries Limited group
- Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy SubjectsCompletedNCT03220633Phase 1
Sponsor listed in the registry: Antibe Therapeutics Inc. · Antibe Therapeutics Inc. — acquired company within the Sun Pharmaceutical Industries Limited group